If youre not getting the desired results, its important to talk to your healthcare provider
The article says semaglutide works on GLP-1 receptors alone, regulating blood sugar, appetite, and gastric emptying, while tirzepatide engages both GLP-1 and GIP receptors, potentially amplifying insulin release and satiety signalling
Slowing down glucose release: By reducing the release of glucose from the stomach, it effectively stabilizes blood sugar levels
Those factors could independently reduce substance use disorder risk, separate from any drug effect
People taking GLP-1 agonist medications have experienced improved blood pressure and cholesterol levels
Ipamorelin and IGF-1 Response Ipamorelin functions as a ghrelin receptor (GHS-R1a) agonist and is primarily studied for its ability to stimulate pulsatile GH release